stockrowIMMURON (IMRN) vs Kiora Pharmaceuticals, Inc. (KPRX)
- IMMURON IMRN 0.82 −3.53%
- Kiora Pharmaceuticals, Inc. KPRX 1.42 −5.33%
IMMURON and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. IMMURON and Kiora Pharmaceuticals, Inc. are of similar size ($6.9M and $6.6M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −6.62%. Kiora Pharmaceuticals, Inc. has the higher net margin (0.00% vs −262.7%) and the lower return on invested capital (−44,053.9% vs 0.00%). Across the 14 metrics below, IMMURON leads on 8 and Kiora Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | IMRN | KPRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 71.28% | 85.06% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (262.71%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (56.36%) | (51.96%) |
| Return on assets | 0.00% | (39.43%) | (46.06%) |
| Return on invested capital | 0.00% | (44,053.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack